Although this study currently only observed a descriptive association between VMHC reduction and depression/anxiety scores, increasing neuroimmunological evidence suggests that peripheral and central interleukin 6 (IL-6) and tumour necrosis factor-alpha (TNF-α) and other inflammatory cytokines may be the key molecular bridges connecting this functional connectivity defect with emotional disorders. Here, IL6 is linked to depressive symptom measurement.